103 patients with obstructive epiphora, or illacrimation, underwent endonasal lacrimal surgery (dacryocystorhinostomy in the modification of Veis-Cdlaus and canaliculorhinostomy). Postoperative complications included local infections and were seen in 7 cases (6.8%). After finishing the treatment 90 patients (87.4%, Table 4) were free of symptoms and remained so for years of follow-up. Recurrent stenosis developed in 13 cases (12.6%). DS-DCG provides valuable information for confirming the indication for surgery and determining the surgical procedure in obstructive epiphora. In addition it may help to assess a successful outcome of the operation in the course of treatment (Fig. 7 and 8). By means of real time substraction the successive opacification is visualised on the monitor screen during injection thus controlling the examination. Incomplete contrast filling and overopacification are avoided. Digitalisation may direct the extent of homogenisation of the background of the radiographic image. Anatomical structures are preserved and weakly contrasted structures are depicted precisely and independent of the background. Stenoses before (Fig. 2 and 3), within (Fig. 4) and behind (Fig. 6) the lacrimal sac can be differentiated from complete, incomplete (Fig. 4) and functional stenoses.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.